OP-26A - Evaluation of the Potential Confounding Effect of Shingles on the Risk of Guillain-barré Syndrome After Vaccination with the Recombinant Zoster Vaccine
Location: OP-26
Vaccines
Monday, Aug 23rd
1:45 PM - 3:30 PM US Eastern Time
OP-26C - Sensitivity Analysis of Design Choices for Estimating Incidence Rates of Adverse Events of Special Interest in Vaccine Safety
Location: OP-26
Vaccines
Monday, Aug 23rd
1:45 PM - 3:30 PM US Eastern Time
OP-26D - Effectiveness of Influenza Vaccination in Healthy Children: A Population-based Investigation
Location: OP-26
Vaccines
Monday, Aug 23rd
1:45 PM - 3:30 PM US Eastern Time
OP-26E - Background Incidence Rates of Adverse Events of Special Interest for COVID-19 Vaccine Monitoring
Location: OP-26
Vaccines
Monday, Aug 23rd
1:45 PM - 3:30 PM US Eastern Time
OP-26F - Vaccination and Acute Flares in Multiple Sclerosis: A Nationwide Case-crossover Study Using the French SNDS Health Care Databases
Location: OP-26
Vaccines
Tuesday, Aug 24th
10:00 AM - 11:30 AM US Eastern Time
WS-09 - Methodological Approaches to Evaluating the Safety and Effectiveness of Multi-dose Coronavirus Disease 2019 (COVID-19) Vaccines Series
Location: WS-09
Vaccines
Tuesday, Aug 24th
5:15 PM - 6:30 PM US Eastern Time
SP17 - The Effect of Prioritization and Second Dose Interval Choice on the Effectiveness of COVID-19 Vaccination in Europe: An Agent-based Cohort Model
Location: SP17
Vaccines
Tuesday, Aug 24th
5:15 PM - 6:30 PM US Eastern Time
SP17A - Seasonal Patterns in Vaccine Administration and Outcome Occurrence – a Potential Source of Artifact in Self-controlled Safety Study Designs
Location: SP17
Vaccines
Tuesday, Aug 24th
5:15 PM - 6:30 PM US Eastern Time
SP17D - Anogenital Warts and the Introduction of the Quadrivalent HPV Vaccine Program in Manitoba, Canada
Location: SP17
Vaccines
Tuesday, Aug 24th
5:15 PM - 6:30 PM US Eastern Time
SP17G - Assessment of Thyroiditis Risk Associated with HPV Vaccination Among Girls Aged 9-18 Years: A Time-varying Cohort Study
Location: SP17
Vaccines
Tuesday, Aug 24th
5:15 PM - 6:30 PM US Eastern Time
SP17H - The Safety and Immunologic Effectiveness of the Live Varicella Zoster Vaccine in Patients Receiving Tumor Necrosis Factor Inhibitor Therapy: A Randomized Controlled Trial
Location: SP17
Vaccines
Tuesday, Aug 24th
5:15 PM - 6:30 PM US Eastern Time
SP17J - Impact of 2011/2012 ACIP Maternal Pertussis Vaccination Recommendations on Infant Pertussis Mortality in the US
Location: SP17
Vaccines
Wednesday, Aug 25th
8:30 AM - 10:00 AM US Eastern Time
PLEN-3 - COVID-19 Vaccines: Timely Global Real-world Evidence
Location: PLEN-3
Vaccines
Wednesday, Aug 25th
11:45 AM - 1:30 PM US Eastern Time
OP-5A - Descriptive Epidemiology of Adverse Events of Special Interest for COVID-19 Vaccines Across 7 Countries and 4 Continents: A Multinational Network Cohort Study
Location: OP-05
Vaccines
Wednesday, Aug 25th
8:00 PM - 9:30 PM US Eastern Time
PLEN-3B - REPEAT: COVID-19 Vaccines: Timely Global Real-world Evidence
